Porphyrin derivatives and their use in photon activation therapy
US7816518B2 · kind B2 · utility
1Cited by
2References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 8, 2005 |
| Grant date | Oct 19, 2010 |
| Priority date | — |
| Expiry date | Dec 31, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of a compound of formula (I) in the manufacture of a pharmaceuticals composition for cell death by photo activation therapy and the use of the compounds in the prevention and/or treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.